Hutchinson–Gilford–Progeria syndrome
Hutchinson–Gilford Progeria Syndrome (HGPS) is a rare, fatal, genetic condition characterized by an appearance of accelerated aging in children. It is named after the two British doctors, Jonathan Hutchinson and Hastings Gilford, who first described it in the late 19th century.
Etiology[edit | edit source]
HGPS is caused by a mutation in the LMNA gene, which encodes the lamin A protein. This protein provides structural support to the nucleus of the cell. In HGPS, a mutated form of lamin A, known as progerin, accumulates in the nucleus, leading to progressive damage and premature cell death.
Clinical Features[edit | edit source]
Children with HGPS typically appear normal at birth. However, within a year, they begin to display signs of accelerated aging, such as growth retardation, loss of body fat and hair, aged-looking skin, stiffness of joints, and atherosclerosis. Despite their aged appearance, these children have normal cognitive development.
Diagnosis[edit | edit source]
Diagnosis of HGPS is based on the characteristic clinical features. Genetic testing can confirm the diagnosis by identifying the mutation in the LMNA gene.
Treatment[edit | edit source]
There is currently no cure for HGPS. Treatment is supportive and aims to improve the quality of life and slow the progression of the disease. This may include low-dose aspirin to prevent heart attacks and strokes, physical and occupational therapy to improve joint mobility, and nutritional support to maintain body weight.
Prognosis[edit | edit source]
The average life expectancy for individuals with HGPS is about 13 years, with most dying from heart disease or stroke. However, with advances in research and supportive care, some individuals have lived into their late teens and early twenties.
Research[edit | edit source]
Research into HGPS is ongoing, with the aim of understanding the disease process and developing effective treatments. This research may also provide insights into the normal aging process and age-related diseases, such as heart disease and Alzheimer's disease.
NIH genetic and rare disease info[edit source]
Hutchinson–Gilford–Progeria syndrome is a rare disease.
| Hutchinson–Gilford–Progeria syndrome Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
